Syndecan 1 also has been linked with cancer progression by mediating the effects of growth factors in the cells.

These breakthroughs revolutionized our understanding of molecular events driving cancer progression.

Deficient vitamin D levels also increased the chances of cancer progression.

Later studies showed much less ability of Avastin to forestall cancer progression when combined with other drugs.

Among the efforts is a search for new ways to measure cancer progression.

In this application, biomarkers act as stand-ins for the effects of a drug on cancer progression and survival.

Metastasis is one of the key steps in cancer progression that causes cancer-related deaths.

They have also studied the role of copy number alterations in cancer progression to metastasis.

Since these genes are highly conserved in humans, there is evidence that they play a role in cancer progression.

Constitutive activation of Stat3 has been associated with cell transformation and cancer progression.